- Adipose Tissue-Derived Stem Cells
- Human Neurons
- Mouse Probe
- Whole Chromosome Painting Probes
- Hepatic Cells
- Renal Cells
- In Vitro ADME Kits
- Tissue Microarray
- Tissue Blocks
- Tissue Sections
- FFPE Cell Pellet
- Probe
- Centromere Probes
- Telomere Probes
- Satellite Enumeration Probes
- Subtelomere Specific Probes
- Bacterial Probes
- ISH/FISH Probes
- Exosome Isolation Kit
- Human Adult Stem Cells
- Mouse Stem Cells
- iPSCs
- Mouse Embryonic Stem Cells
- iPSC Differentiation Kits
- Mesenchymal Stem Cells
- Immortalized Human Cells
- Immortalized Murine Cells
- Cell Immortalization Kit
- Adipose Cells
- Cardiac Cells
- Dermal Cells
- Epidermal Cells
- Peripheral Blood Mononuclear Cells
- Umbilical Cord Cells
- Monkey Primary Cells
- Mouse Primary Cells
- Breast Tumor Cells
- Colorectal Tumor Cells
- Esophageal Tumor Cells
- Lung Tumor Cells
- Leukemia/Lymphoma/Myeloma Cells
- Ovarian Tumor Cells
- Pancreatic Tumor Cells
- Mouse Tumor Cells
- Specification
- Q & A
- Customer Review
Pour the culture medium in the culture bottle into a clean test tube, add 0.25% trypsin-0.02% EDTA mixed digestion solution 1 mL into the test tube, leave it for 3-5 minutes, wait until you see the cells become round and not connected to each other, then gently blow to make cell suspension.
Ask a Question
Average Rating: 4.0 | 1 Scientist has reviewed this product
Satisfied
I'm really satisfied with the performance of this product.
18 Jan 2022
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: This line has never been trypsinized; however, the variant LS 174T (ATCC CL-188) has been subcultured by trypsinization.
Description: Established from a woman with a moderately differentiated primary adenocarcinoma of the right colon (TNM stage 2)
Description: Subline of HCT116 cell line lacking Ligase 3 gene in one allele.
Description: The C84 cell line was established from a 67-year old male patient with a poorly differentiated adenocarcinoma of the caecum classified as Dukes' stage C
Description: Genetically modified HRA-19a1.1 cells expressing a chimeric alpha2 integrin with the extracellular and transmembrane domain of alpha2 integrin and the cytoplasmic domain of alpha1 integrin